Analyst Josh Sullivan of Benchmark Co. reiterated a Buy rating on Odysightai (ODYS – Research Report), retaining the price target of $10.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Josh Sullivan’s rating is based on Odysightai’s strong performance and strategic shift towards the Aerospace & Defense and Industrial Technology sectors. The company exceeded revenue expectations for the first quarter of 2025, reporting a significant year-over-year increase. This growth was partly due to the full derecognition of a contract liability with a major medical customer, yet even without this impact, Odysightai surpassed revenue estimates.
Additionally, Odysightai has successfully transitioned its focus from healthcare to a robust backlog in Aerospace & Defense and Industrial markets, with notable clients such as the Israeli Air Forces and NASA. The company has also secured a new purchase order from a European industrial client, demonstrating its expanding market reach. With substantial cash reserves, Odysightai is well-positioned to capitalize on global opportunities in predictive and condition-based maintenance, supporting Sullivan’s Buy rating.